Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Stanford University
Goals of the study are as follows:
* To evaluate the ability to predict and track brain network changes during TMS treatment for medication-resistant depression.
* To develop quantitative tools that measure the connectivity and excitability of the brain using resting and single pulse TMS-EEG.
* To determine the feasibility of recording EEG biomarkers in the clinic without disrupting clinical care.
Age
18–60
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men and women, ages 18 to 60
Medication-resistant depression as assessed by psychiatrist
Must comprehend English well to ensure adequate comprehension of the EEG and TMS instructions, and of clinical scales
Has failed \>1 previous adequate antidepressant medication trials
Right-handed
No current or history of neurological disorders
No seizure disorder or risk of seizures
No use of PRN medication within 48 hours of the scheduled study appointment
You may not be if
Any unstable medical condition, any significant CNS neurological condition such as stroke, seizure, tumor, hemorrhage, multiple sclerosis, etc
Current electroconvulsive therapy (ECT) or prior treatment failure with ECT
Currently pregnant or breastfeeding
Clareo Health | Brain-Based Biomarkers in Response to TMS in MDD
